---
title: "CGEN.US (CGEN.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CGEN.US/news.md"
symbol: "CGEN.US"
name: "CGEN.US"
parent: "https://longbridge.com/zh-CN/quote/CGEN.US.md"
datetime: "2026-03-13T01:27:12.950Z"
locales:
  - [en](https://longbridge.com/en/quote/CGEN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CGEN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CGEN.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/CGEN.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CGEN.US/news.md)


# CGEN.US (CGEN.US) — 相关新闻

### [12 Health Care Stocks Moving In Monday's Intraday Session](https://longbridge.com/zh-CN/news/277500827.md)
*2026-03-02T17:05:47.000Z*
> In Monday's trading session, several health care stocks experienced significant movements. Rallybio (RLYB) surged 25.6% 

### [Uncovering Potential: Compugen's Earnings Preview](https://longbridge.com/zh-CN/news/277239738.md)
*2026-02-27T19:01:26.000Z*
> Compugen (NASDAQ:CGEN) will report its quarterly earnings on March 2, 2026, with analysts estimating an EPS of $0.10. Th

### [Compugen (NASDAQ: CGEN) to release Q4 and full year 2025 results on March 2, 2026. Headquarters: Holon, Israel.](https://longbridge.com/zh-CN/news/276122438.md)
*2026-02-17T12:03:23.000Z*
> In Holon, Israel, on February 17, 2026, Compugen Ltd. revealed it will be presenting its financial results for the fourt

### [](https://longbridge.com/zh-CN/news/272106136.md)
*2026-01-09T16:53:39.000Z*
> Compugen shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and annou

### [Compugen Sells Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million](https://longbridge.com/zh-CN/news/270006427.md)
*2025-12-17T12:01:33.000Z*
### [Compugen (CGEN) Receives a Buy from Truist Financial](https://longbridge.com/zh-CN/news/265354547.md)
*2025-11-11T13:05:52.000Z*
> Truist Financial analyst Asthika Goonewardene has reiterated a Buy rating on Compugen (CGEN) with a price target of $4.0